More than a million people a year are already dying from infections caused by microbes that are resistant to treatment – it's ...

BiomX has published promising phase 1b/2a trial results in Nature Communications, demonstrating that its phage cocktail BX004 ...

First patient dosing in Company’s Phase 2b trial marks pivotal milestone in phage therapy development program targeting ...

Novel AI-powered laboratory test for diagnosis of Barrett's esophagus, with or without dysplasia SUFFERN, NEW YORK / ACCESS Newswire / July 24, 2025 / CDx Diagnostics announced today that the U.S.

BiomX has dosed the first subject in the randomised Phase IIb trial of the company’s fixed multi-phage therapy, BX004, to ...

For hundreds of years, people have flocked to a churchyard in a small village in Northern Ireland to gather handfuls of soil ...

A host of scientific investigations await the crew of NASA's SpaceX Crew-11 mission during their long-duration expedition ...

A new method is allowing researchers to track and analyze eye movements in fish. The technology is helping a research team ...

Find out what today's Wordle hint and answer is and get some tips for it, plus see the solutions to previous games.

Investing.com -- BiomX (NYSE: PHGE) Inc. (NYSE American:PHGE) stock surged 60% after the clinical-stage company announced it has successfully initiated patient dosing in its Phase 2b trial evaluating ...

Nagpur: Researchers have unveiled the rich microbial diversity and antimicrobial potential of the glacier-fed upper stretch of the Ganges River, in a .

Transmembrane proteins (TPs), also referred to as ‘integral membrane proteins’, make up between 70 % and 80 % of the total ...